| Code | Description | Claims | Beneficiaries | Total Paid |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
11,135 |
3,859 |
$585K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
308 |
270 |
$514K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
8,100 |
2,653 |
$435K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,593 |
3,350 |
$434K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,758 |
6,034 |
$429K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,512 |
5,014 |
$373K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
37,648 |
28,198 |
$330K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,701 |
1,636 |
$183K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
7,605 |
2,506 |
$172K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,282 |
2,067 |
$167K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,498 |
2,274 |
$159K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,949 |
2,726 |
$153K |
| 87631 |
|
1,403 |
1,357 |
$152K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,128 |
2,778 |
$122K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,346 |
1,987 |
$118K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,144 |
2,028 |
$113K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
28,282 |
21,593 |
$107K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
766 |
668 |
$95K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
471 |
452 |
$85K |
| 80053 |
Comprehensive metabolic panel |
16,223 |
13,481 |
$84K |
| 92523 |
|
612 |
597 |
$83K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,281 |
1,404 |
$82K |
| 92526 |
|
1,418 |
685 |
$78K |
| 71046 |
Radiologic examination, chest; 2 views |
6,661 |
6,117 |
$60K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,831 |
910 |
$56K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
385 |
371 |
$52K |
| 76830 |
Ultrasound, transvaginal |
773 |
736 |
$45K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
699 |
660 |
$40K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
789 |
757 |
$39K |
| 84112 |
|
495 |
436 |
$38K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
534 |
504 |
$35K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
657 |
562 |
$34K |
| 97166 |
|
681 |
649 |
$34K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,071 |
1,051 |
$33K |
| 97162 |
|
837 |
809 |
$32K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
503 |
78 |
$32K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,588 |
6,142 |
$32K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
386 |
361 |
$31K |
| 36415 |
Collection of venous blood by venipuncture |
21,572 |
15,915 |
$30K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
729 |
683 |
$30K |
| 97161 |
|
595 |
577 |
$29K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,241 |
6,930 |
$29K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
223 |
129 |
$29K |
| 80047 |
|
4,270 |
3,850 |
$28K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
385 |
368 |
$28K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
579 |
562 |
$27K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
235 |
221 |
$27K |
| 93017 |
|
444 |
432 |
$25K |
| 92610 |
|
430 |
416 |
$25K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,028 |
981 |
$25K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
421 |
395 |
$24K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,382 |
3,091 |
$24K |
| 82948 |
|
8,633 |
4,730 |
$23K |
| 93976 |
|
152 |
145 |
$23K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,286 |
4,601 |
$22K |
| 76770 |
|
470 |
454 |
$22K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
306 |
304 |
$22K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
541 |
515 |
$21K |
| 81025 |
|
4,281 |
3,957 |
$20K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
631 |
290 |
$20K |
| G0378 |
Hospital observation service, per hour |
1,002 |
797 |
$20K |
| 81003 |
|
11,184 |
9,646 |
$19K |
| 76801 |
|
375 |
332 |
$19K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,986 |
3,319 |
$19K |
| 76642 |
|
567 |
468 |
$19K |
| 84484 |
|
5,290 |
3,802 |
$18K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
817 |
563 |
$18K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
379 |
333 |
$16K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
192 |
190 |
$15K |
| 83690 |
|
4,659 |
4,084 |
$15K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
5,886 |
3,967 |
$14K |
| 83880 |
|
1,343 |
1,192 |
$13K |
| 87040 |
|
2,272 |
1,222 |
$13K |
| 97113 |
|
362 |
151 |
$13K |
| 83735 |
|
4,760 |
3,583 |
$13K |
| 85610 |
|
7,365 |
4,838 |
$12K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
178 |
173 |
$12K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
372 |
364 |
$11K |
| 83605 |
|
2,276 |
1,862 |
$11K |
| 80076 |
|
2,326 |
2,089 |
$11K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
374 |
365 |
$11K |
| 73221 |
|
89 |
87 |
$10K |
| 83874 |
|
1,775 |
1,455 |
$10K |
| 97750 |
|
241 |
222 |
$10K |
| 71250 |
|
273 |
254 |
$10K |
| J2785 |
Injection, regadenoson, 0.1 mg |
244 |
243 |
$10K |
| 73562 |
|
705 |
607 |
$9K |
| 73110 |
|
558 |
501 |
$9K |
| 74018 |
|
767 |
674 |
$9K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,555 |
6,486 |
$9K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
115 |
108 |
$8K |
| 73630 |
|
689 |
619 |
$8K |
| 71045 |
Radiologic examination, chest; single view |
2,385 |
2,080 |
$8K |
| 73610 |
|
620 |
575 |
$8K |
| 70486 |
|
163 |
156 |
$8K |
| 84702 |
|
582 |
520 |
$8K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,767 |
1,653 |
$7K |
| 99490 |
Ccm add 20min |
1,527 |
1,414 |
$7K |
| 87641 |
|
366 |
356 |
$7K |
| 73130 |
|
540 |
450 |
$7K |
| 73030 |
|
710 |
618 |
$7K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
94 |
86 |
$6K |
| 86850 |
|
1,047 |
906 |
$6K |
| 96415 |
|
97 |
80 |
$6K |
| 97116 |
|
298 |
125 |
$6K |
| 20610 |
|
295 |
252 |
$6K |
| 72110 |
|
353 |
337 |
$6K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
172 |
171 |
$5K |
| 82550 |
|
1,727 |
1,520 |
$5K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,983 |
2,478 |
$5K |
| 77066 |
Tomosynthesis, mammo |
74 |
68 |
$5K |
| 87430 |
|
441 |
427 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
144 |
143 |
$5K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
359 |
336 |
$5K |
| 87077 |
|
1,039 |
989 |
$5K |
| 87186 |
|
900 |
862 |
$5K |
| 85380 |
|
836 |
794 |
$5K |
| 84520 |
|
1,911 |
1,774 |
$4K |
| 73502 |
|
428 |
388 |
$4K |
| 77065 |
Tomosynthesis, mammo |
87 |
68 |
$4K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
45 |
40 |
$4K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
907 |
835 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,437 |
2,485 |
$4K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
317 |
292 |
$4K |
| 87070 |
|
672 |
591 |
$4K |
| 82803 |
|
325 |
277 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,997 |
2,759 |
$4K |
| 72141 |
|
45 |
41 |
$4K |
| 86900 |
|
1,179 |
1,023 |
$4K |
| 76536 |
|
57 |
57 |
$4K |
| 36592 |
|
484 |
423 |
$4K |
| 86901 |
|
1,179 |
1,024 |
$4K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
617 |
567 |
$4K |
| 74230 |
|
47 |
41 |
$3K |
| 86140 |
|
1,090 |
955 |
$3K |
| 85730 |
|
986 |
903 |
$3K |
| 77002 |
|
105 |
97 |
$3K |
| J1453 |
Injection, fosaprepitant, 1 mg |
19 |
14 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,132 |
3,642 |
$3K |
| 86780 |
|
220 |
205 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,737 |
1,761 |
$3K |
| 70491 |
|
37 |
37 |
$3K |
| Q3014 |
Telehealth originating site facility fee |
722 |
596 |
$3K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
70 |
44 |
$3K |
| 87081 |
|
465 |
450 |
$3K |
| 93880 |
|
66 |
65 |
$3K |
| 36416 |
|
3,165 |
1,570 |
$3K |
| 77080 |
|
365 |
358 |
$2K |
| 70544 |
|
26 |
26 |
$2K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
59 |
55 |
$2K |
| 87210 |
|
543 |
502 |
$2K |
| 82728 |
|
381 |
344 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,569 |
1,040 |
$2K |
| 80061 |
Lipid panel |
501 |
471 |
$2K |
| 87205 |
|
693 |
603 |
$2K |
| 85027 |
|
1,691 |
1,306 |
$2K |
| 87634 |
|
28 |
27 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
618 |
348 |
$2K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
31 |
26 |
$2K |
| 97535 |
Self-care/home management training, each 15 minutes |
63 |
41 |
$2K |
| G0008 |
Administration of influenza virus vaccine |
853 |
823 |
$2K |
| 85651 |
|
608 |
538 |
$2K |
| 90686 |
|
468 |
458 |
$2K |
| 97010 |
|
579 |
233 |
$2K |
| 84100 |
|
462 |
396 |
$2K |
| 97165 |
|
27 |
25 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
141 |
110 |
$1K |
| 92611 |
|
41 |
38 |
$1K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
28 |
26 |
$1K |
| 87075 |
|
210 |
177 |
$1K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
13 |
13 |
$1K |
| 73080 |
|
87 |
80 |
$1K |
| 82565 |
|
658 |
580 |
$1K |
| 72050 |
|
54 |
46 |
$998.60 |
| 81001 |
|
2,344 |
2,065 |
$966.95 |
| 85055 |
|
43 |
36 |
$927.63 |
| 84145 |
|
45 |
44 |
$873.19 |
| 82731 |
|
16 |
16 |
$858.82 |
| 73140 |
|
64 |
58 |
$803.51 |
| 73590 |
|
69 |
64 |
$728.72 |
| 72100 |
|
43 |
40 |
$659.51 |
| 81002 |
|
325 |
269 |
$655.07 |
| 82570 |
|
972 |
868 |
$651.61 |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
14 |
13 |
$604.39 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,064 |
793 |
$593.72 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
30 |
29 |
$545.50 |
| 82962 |
|
480 |
432 |
$540.05 |
| 72082 |
|
14 |
14 |
$530.04 |
| 73090 |
|
47 |
41 |
$526.25 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
290 |
283 |
$520.02 |
| 84439 |
|
83 |
80 |
$500.87 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
236 |
63 |
$485.06 |
| 76937 |
|
35 |
27 |
$453.87 |
| 83615 |
|
95 |
77 |
$449.58 |
| 80069 |
|
179 |
135 |
$395.98 |
| 82947 |
|
93 |
77 |
$390.26 |
| 76870 |
|
14 |
14 |
$383.72 |
| 73564 |
|
33 |
29 |
$383.12 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
236 |
204 |
$345.43 |
| G0009 |
Administration of pneumococcal vaccine |
108 |
105 |
$297.49 |
| 72072 |
|
28 |
26 |
$281.43 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,701 |
1,523 |
$277.98 |
| 36591 |
|
125 |
64 |
$268.80 |
| 99152 |
|
177 |
158 |
$267.48 |
| 83540 |
|
135 |
125 |
$236.04 |
| 82274 |
|
28 |
27 |
$235.30 |
| 76857 |
|
13 |
12 |
$234.78 |
| 90670 |
|
16 |
15 |
$231.57 |
| 90662 |
|
208 |
198 |
$219.78 |
| 73521 |
|
12 |
12 |
$215.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,070 |
1,050 |
$204.84 |
| 74022 |
|
13 |
13 |
$193.81 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16 |
16 |
$187.58 |
| 83550 |
|
94 |
88 |
$174.14 |
| 74019 |
|
12 |
12 |
$164.75 |
| 85014 |
|
73 |
53 |
$162.49 |
| 82330 |
|
96 |
79 |
$152.95 |
| 85652 |
|
165 |
149 |
$144.36 |
| 77001 |
|
15 |
12 |
$132.26 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
543 |
507 |
$125.00 |
| C1769 |
Guide wire |
64 |
60 |
$123.26 |
| 85007 |
|
602 |
483 |
$121.34 |
| 96376 |
|
556 |
450 |
$110.24 |
| 80051 |
|
15 |
13 |
$108.49 |
| 99153 |
Mod sedat endo service >5yrs |
57 |
49 |
$87.08 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,099 |
808 |
$75.14 |
| 0296T |
|
12 |
12 |
$73.80 |
| 90732 |
|
15 |
15 |
$71.21 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
367 |
308 |
$70.66 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
278 |
255 |
$65.57 |
| 84156 |
|
53 |
37 |
$63.63 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
17 |
16 |
$56.94 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
28 |
27 |
$51.85 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
108 |
106 |
$50.52 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
54 |
54 |
$45.91 |
| 84550 |
|
14 |
12 |
$41.09 |
| 99487 |
Ccm add 20min |
17 |
12 |
$40.59 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
267 |
254 |
$40.33 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
266 |
224 |
$26.60 |
| J1245 |
Injection, dipyridamole, per 10 mg |
31 |
28 |
$18.90 |
| J2704 |
Injection, propofol, 10 mg |
1,096 |
988 |
$17.32 |
| 82077 |
|
121 |
109 |
$16.22 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
12 |
12 |
$8.03 |
| 82043 |
|
24 |
24 |
$5.92 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
136 |
120 |
$5.09 |
| 84295 |
|
109 |
94 |
$1.56 |
| 82247 |
|
20 |
14 |
$1.56 |
| 84155 |
|
30 |
27 |
$1.56 |
| 84075 |
|
20 |
14 |
$1.56 |
| 82040 |
|
19 |
13 |
$1.56 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
20 |
13 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
13 |
13 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
15 |
14 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
83 |
74 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
29 |
25 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
248 |
194 |
$0.00 |
| 80320 |
|
167 |
142 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
15 |
12 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
98 |
80 |
$0.00 |
| 82435 |
|
94 |
80 |
$0.00 |
| C1889 |
Implantable/insertable device, not otherwise classified |
165 |
146 |
$0.00 |
| 84132 |
|
79 |
65 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
16 |
13 |
$0.00 |
| 85018 |
|
15 |
12 |
$0.00 |